Main David

CIK 00015999411 companyVANCOUVER, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001599941

Recent Transactions

19 trades

Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2018-08-07+415,000→ 415,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2018-03-09+225,000→ 225,000 total
Exercise/Conversion
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2017-06-05−3,625→ 0 total
Sale
Neurogene Inc.$NGNE
Common Stock
2017-06-05$13.16/sh−3,625→ 71,530 total
Exercise/Conversion
Neurogene Inc.$NGNE
Common Stock
2017-06-05$9.60/sh+3,625→ 75,155 total
Exercise/Conversion
Neurogene Inc.$NGNE
Common Stock
2017-06-02$9.60/sh+6,000→ 77,530 total
Sale
Neurogene Inc.$NGNE
Common Stock
2017-06-02$13.59/sh−6,000→ 71,530 total
Exercise/Conversion
Neurogene Inc.$NGNE
Stock Option (Right to Buy(
2017-06-02−6,000→ 3,625 total
Sale
Neurogene Inc.$NGNE
Common Stock
2017-06-01$13.00/sh−6,000→ 71,530 total
Exercise/Conversion
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2017-06-01−6,000→ 9,625 total
Exercise/Conversion
Neurogene Inc.$NGNE
Common Stock
2017-06-01$9.60/sh+6,000→ 77,530 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2017-03-08+185,000→ 185,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2016-03-10+120,000→ 120,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2015-03-12+65,000→ 65,000 total
Disposition to Issuer
Neurogene Inc.$NGNE
Common Exchangeable Shares
2014-03-12$11.00/sh−9,459→ 0 total
Disposition to Issuer
Neurogene Inc.$NGNE
Common Special Voting Stock
2014-03-12$11.00/sh−9,459→ 71,530 total
Conversion
Neurogene Inc.$NGNE
Common Stock
2014-03-12+71,530→ 71,530 total
Conversion
Neurogene Inc.$NGNE
Common Special Voting Stock
2014-03-12−71,530→ 0 total
Conversion
Neurogene Inc.$NGNE
Common Exchangeable Shares
2014-03-12−71,530→ 0 total

Companies

Neurogene Inc.
Director, President and CEO
$NGNE

Recent Filings

Address

C/O AQUINOX PHARMACEUTICALS INC. 40 - 887 GREAT NORTHERN WAY

VANCOUVER, A1, V5T 4T5

View on SEC.gov